[Form 4] Organogenesis Holdings Inc. Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

4

Rhea-AI Filing Summary

Analyzing...

07/18/2025 - 04:13 PM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Organogenesis Hldgs Inc

NASDAQ:ORGO

ORGO Rankings

#4041 Ranked by Market Cap

N/A Ranked by Dividends

ORGO Latest News

Jul 15, 2025

Organogenesis Applauds CMS Proposal to Reform Skin Substitute Payment Policy; Urges Refinements to Ensure Patient Access to Appropriate Products and Continued Innovation

May 8, 2025

Organogenesis Holdings Inc. Reports First Quarter 2025 Financial Results

Apr 11, 2025

Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness

Apr 7, 2025

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Feb 27, 2025

Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results

ORGO Latest SEC Filings

Jun 26, 2025

[SCHEDULE 13D/A] Organogenesis Holdings Inc. SEC Filing

Jun 24, 2025

[8-K] Organogenesis Holdings Inc. Reports Material Event

ORGO Stock Data

Market Cap 558.16M

Float 67.69M

Insiders Ownership 46.66%

Institutions Ownership 49.76%

Short Percent 6.8%

Industry Drug Manufacturers - Specialty & Generic

Sector Pharmaceutical Preparations

Website Link

Country United States

City CANTON